Capecitabine Has Edge in CRT for Pancreatic Ca

SAN FRANCISCO (MedPage Today) -- When paired with chemoradiotherapy, capecitabine offered better survival and toxicity outcomes than gemcitabine in locally advanced pancreatic cancer, researchers reported here.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news